Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial

被引：1

作者：

Scheffold, Annika ^{[1
]}

Jebaraj, Billy Michael Chelliah ^{[1
]}

Jaramillo, Sonia ^{[1
]}

Tausch, Eugen ^{[1
]}

Steinbrecher, Daniela ^{[1
]}

Hahn, Michael ^{[2
]}

Boettcher, Sebastian ^{[3
]}

Ritgen, Matthias ^{[3
]}

Bunjes, Donald ^{[1
]}

Zeis, Matthias ^{[4
]}

Stadler, Michael ^{[5
]}

Uharek, Lutz ^{[6
]}

Scheid, Christoph ^{[7
]}

Hegenbart, Ute ^{[2
]}

Hallek, Michael ^{[7
]}

Kneba, Michael ^{[3
]}

Schmitz, Norbert ^{[4
]}

Doehner, Hartmut ^{[1
]}

Dreger, Peter ^{[2
]}

Stilgenbauer, Stephan ^{[1
]}

机构：

[1] Univ Ulm, Dept Internal Med 3, Ulm, Germany

[2] Heidelberg Univ, Dept Med 5, Heidelberg, Germany

[3] Univ Med Ctr Schleswig Holstein, Dept Med 2, Kiel, Germany

[4] Asklepios Klin St Georg, Dept Haematol & Stem Cell Transplantat, Hamburg, Germany

[5] Hannover Med Sch, Dept Haematol Haemostasis Oncol & Stem Cell Trans, Hannover, Germany

[6] Univ Med Berlin, Charite Campus Virchow Klinikum, Dept Med Haematol Oncol & Tumour Immunol, Berlin, Germany

[7] Univ Cologne, Dept Med 1, Ctr Integrated Oncol Cologne Bonn, Cologne, Germany

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2017年 / 179卷 / 02期

关键词：

Chronic lymphocytic leukaemia; Telomere length; Allogeneic stem cell transplantation; ABERRATIONS; DISEASE;

D O I：

10.1111/bjh.14219

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：342 / 346

页数：5

共 50 条

[1] Telomere Lenght and Outcome of Allogeneic Stem Cell Transplantation for Poor Risk Chronic Lymphocytic Leukemia: Results from the GCLLSG CLL3X Trial
Scheffold, Annika
Jebaraj, Billy Michael Chelliah
Tausch, Eugen
Boettcher, Sebastian
Ritgen, Matthias
Bunjes, Donald
Zeis, Matthias
Stadler, Michael
Uharek, Lutz
Scheid, Christof
Hegenbart, Ute
Hallek, Michael
Kneba, Michael
Schmitz, Norbert
Doehner, Hartmut
Dreger, Peter
Stilgenbauer, Stephan
[J]. BLOOD, 2014, 124 (21)
[2] A prospective multicenter trial on nonmyeloablative allogeneic stem cell transplantation (NST) for poor-risk chronic lymphocytic leukemia (CLL):: Final results of the GCLLSG CLL3X study
Dreger, P.
Stilgenbauer, S.
Boettcher, S.
Ritgen, M.
Busch, R.
Bunjes, D.
Beelen, D.
Cohen, S.
Hegenbart, U.
Schubert, J.
Hertenstein, B.
Stadler, M.
Glass, B.
Burchert, A.
Uharek, L.
Basara, N.
Humpe, A.
Duehrsen, U.
Hallek, M.
Schmitz, N.
Kneba, M.
Doehner, H.
[J]. ANNALS OF ONCOLOGY, 2008, 19 : 102 - 102
[3] Prognostic Factors for Outcome of Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) in Poor-Risk Chronic Lymphocytic Leukemia (CLL): Final Results from a Prospective Multicenter Trial (GCLLSG CLL3X study)
Dreger, Peter
Stilgenbauer, Stephan
Boettcher, Sebastian
Ritgen, Matthias
Dietrich, Sascha
Bunjes, Donald
Beelen, Dietrich Wilhelm
Cohen, Sandra
Hegenbart, Ute
Schubert, Joerg
Stadler, Michael
Glass, Bertram
Burchert, Andreas
Uharek, Lutz
Hallek, Michael
Kneba, Michael
Schmitz, Norbert
Doehner, Hartmut
[J]. BLOOD, 2008, 112 (11) : 212 - 212
[4] MRD mapping identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial
Dreger, P.
Boettcher, S.
Stilgenbauer, S.
Bunjes, D.
Schubert, J.
Cohen, S.
Hallek, M.
Kneba, M.
Schmitz, N.
Doehner, H.
Ritgen, M.
[J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S308 - S308
[5] Allogeneic Stem Cell Transplantation Can Overcome the Adverse Prognostic Impact of TP53 Mutation In Chronic Lymphocytic Leukemia (CLL): Results From the GCLLSG CLL3x Trial
Zenz, Thorsten
Dreger, Peter
Dietrich, Sascha
Boettcher, Sebastian
Ritgen, Matthias
Winkler, Dirk
Buehler, Andreas
Bunjes, Donald
Beelen, Dietrich
Cohen, Sandra
Hegenbart, Ute
Zeis, Matthias
Hallek, Michael
Kneba, Michael
Schmitz, Norbert
Doehner, Hartmut
Stilgenbauer, Stephan
[J]. BLOOD, 2010, 116 (21) : 974 - 975
[6] Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial
Dreger, Peter
Doehner, Hartmut
Ritgen, Matthias
Boettcher, Sebastian
Busch, Raymonde
Dietrich, Sascha
Bunjes, Donald
Cohen, Sandra
Schubert, Joerg
Hegenbart, Ute
Beelen, Dietrich
Zeis, Matthias
Stadler, Michael
Hasenkamp, Justin
Uharek, Lutz
Scheid, Christof
Humpe, Andreas
Zenz, Thorsten
Winkler, Dirk
Hallek, Michael
Kneba, Michael
Schmitz, Norbert
Stilgenbauer, Stephan
[J]. BLOOD, 2010, 116 (14) : 2438 - 2447
[7] Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial
M Ritgen
S Böttcher
S Stilgenbauer
D Bunjes
J Schubert
S Cohen
A Humpe
M Hallek
M Kneba
N Schmitz
H Döhner
P Dreger
[J]. Leukemia, 2008, 22 : 1377 - 1386
[8] Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia:: results from the GCLLSG CLL3X trial
Ritgen, M.
Boettcher, S.
Stilgenbauer, S.
Bunjes, D.
Schubert, J.
Cohen, S.
Humpe, A.
Hallek, M.
Kneba, M.
Schmitz, N.
Doehner, H.
Dreger, P.
[J]. LEUKEMIA, 2008, 22 (07) : 1377 - 1386
[9] QUANTITATIVE MRD MONITORING IDENTIFIES DISTINCT GVL RESPONSE PATTERNS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS FROM THE GCLLSG CLL3X TRIAL
Dreger, P.
Boettcher, S.
Stilgenbauer, S.
Bunjes, D.
Schubert, J.
Cohen, S.
Hallek, M.
Kneba, M.
Dobner, H.
Ritgen, M.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 62 - 62
[10] Long-term outcome of allogeneic hematopoietic stem cell transplantation (HSCT) for chronic lymphocytic leukemia (CLL): 10-year follow-up of the GCLLSG CLL3X trial
Kraemer, I.
Stilgenbauer, S.
Dietrich, S.
Boettcher, S.
Bunjes, D. W.
Zeis, M.
Stadler, M.
Bittenbring, J. T.
Uharek, L.
Scheid, C.
Hegenbart, U.
Ho, A.
Anthony, D.
Hallek, M.
Kneba, M.
Schmitz, N.
Doehner, H.
Dreger, P.
[J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S424 - S424

← 1 2 3 4 5 →